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14.1 Introduction: Background and Driving Forces 
Galactic cosmic rays (GCR) and solar cosmic rays (SCR) are the primary sources of the radiation 
field in space. GCR have their origin in previous cataclysmic astronomical events such as 
supernova explosions. They contain all particles from hydrogen to uranium, all fully ionized, 
with energies up to 1011 GeV and with low fluxes of around a few particles cm-2 s-1. SCR are 
solar energetic particles (SEP) originating from solar flares or shock waves driven by a coronal 
mass ejections (CME), as well as in corotating interaction regions in the interplanetary medium. 
Of most concern for human spaceflight are Solar Proton Events (SPEs) a subgroup of SEP 
events. Such events consist mostly of protons, with a small percentage of heavy ions with 
energies up to several GeV. The duration of the events last from hours to days, in which fluences 
of up to 1011 particles cm-2 can be reached.  
GCR expose biological systems and humans to quite low mean dose rates not leading to acute 
radiation effects, but the exposure causes an additional risk of carcinogenesis, degenerative tissue 
effects, damages to the central nervous system (CNS) and accelerated aging. Exposures to SPE 
also contribute to these listed risks, but in addition may cause acute effects, like performance 
degradation, acute radiation sickness or even death. To prevent exposures due to solar particles 
spacecraft can be equipped with shelters, but shielding is not effective against GCR. While 
effects of high doses are relatively well investigated and reasonably understood, the biological 
effects caused by heavy ions are poorly understood. Mitigation of the effects of heavy ions is one 
of the most important challenges to be solved for the exploration of the solar system. This 
chapter describes the space radiation field, its biological effects and measures that are necessary 
to limit the exposures in space missions to acceptable levels. Laser-driven ion acceleration can 
provide an advanced tool to study heavy ion effects in order to close gaps of knowledge. 
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Humans leaving the Earth to visit other planets of our solar system are therefore exposed to the 
full spectrum of GCR and SCR. Especially critical are exposures during interplanetary travel and 
during Extravehicular Activities (EVA), as well as during excursions on planetary surfaces. 
Habitats on planets can be constructed finally as thick shelters providing sufficient shielding 
thickness to reduce radiation levels to those on Earth. In interplanetary travel only limited 
shielding can be provided by the spacecraft structures; the same holds true for spacesuits. Since 
GCR consists of particles up to extremely high energies, their penetration ability ranges up to 
several hundred centimeters in aluminum. Penetrating the material, GCR loses energy by two 
ways, by the Coulomb interaction and by nuclear collisions. In Coulomb interaction most of the 
energy is transferred to the electrons of the target atoms. In nuclear collisions target and 
projectile fragments are produced. One particle can cause a whole cascade of secondary 
radiation. Having the same energy as the projectiles, projectile fragments penetrate even deeper. 
Excited target atoms may explode thereby producing low energy particles, mostly protons, 
neutrons and alpha particles, which deposit high amounts of energy in small volumes. 
In contrast to GCR, short term exposures by SCR particles may become so high, that life 
threatening exposures become possible. The good message is that the energies of the particles are 
moderate and thus shelters can provide sufficient protection in interplanetary travel. Exposures 
especially during EVA and planetary excursions have to be prevented through adequate 
forecasting and mission planning. 
Radiation effects to be taken into consideration are both, early and late effects. Early radiation 
effects, such as acute radiation sickness, manifest in minutes to days. They occur only through 
elevated exposures by SCR and may cause performance degradation, life span reduction or even 
inflight death. GCR cannot cause early effects due to the low fluence rates, but increases the risk 
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of late effects, from which carcinogenesis and damage to the CNS are of major concern. Late 
effects manifest within years or even decades. 
While radiation effects at high doses are reasonably well understood, this is not the case for low 
doses of heavy ions. The exposure is not homogenous, since some cells in the human body are 
exposed and some are not. Heavy ions deposit a large amount of energy along their path with a 
core of about 50 nm around it followed by a very rapid decrease of the energy transfer with 
increasing distance from the path center due to so-called delta electrons. One ion hitting the 
nucleus of a cell may cause cell death [e.g. Bücker 1974, Reitz 1995].  
The main target is the DNA in the cell nucleus, where a single heavy ion can cause complex 
damages consisting of single strand breaks (SSBs), base damages and double strand breaks 
(DSBs), while sparsely ionizing particles like protons mostly produce single strand breaks. 
Whereas SSBs can be repaired easily by the cell, DSBs are difficult to repair and are potentially 
mutagenic and lethal (see section 14.4.1). Although the flux of heavy ions is low, they represent 
the major contributor to radiation risk in space missions. Since the biological effects of heavy 
ions are poorly understood they represent the main source of uncertainties in risk estimates. 
Preparing a mission to Mars requires an extensive ground-based radiobiological program to 
achieve the reduction of uncertainties in radiation risk assessment and the development of 
appropriate countermeasures. The major facility is the NASA Space Radiation Laboratory 
(NSRL), established by NASA at the Brookhaven National Laboratory on Long Island (NY), 
followed by the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan. The NASA Space 
Radiation Health Program is by far the most intense undertaking towards mitigating the 
radiobiological risk in explorative missions (see website 
http://humanresearchroadmap.nasa.gov/). A strong collaboration between Europe and NASA 
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was envisaged in the IBER Program (see website 
https://www.gsi.de/work/forschung/biophysik/esa_iber.htm), the first European Accelerator-
based Research Program (EARP) [Durante 2007] performed at GSI (GSI Helmholtzzentrum für 
Schwerionenforschung). Having supported the performance of 25 experiments the program was 
terminated due to the on-going construction of the new facility, Facility for Antiproton and ION 
Research (FAIR) at GSI. New beam times have become recently available as part of a “FAIR 
phase 0” transitional program allowing to implement a new IBER research program for the 
period of 2018 until 2022. After FAIR becomes available the IBER program will need to be 
continued and intensified having a facility which has the potential to become the leading facility 
worldwide for space radiobiology. A further facility, but only providing relatively low heavy ion 
energies up to 100 MeV/n is the Grand Accélérateur National de Ions Lourds (GANIL) in Caen, 
France, with its biological facility Laboratoire d' Accueil et de Recherche avec les Ions Accélérés 
(LARIA ). More facilities around the world exist, but most of them suffer either providing the 
appropriate particles and energies or from the provision of the infrastructures, such as biological 
laboratories and animal facilities. The accelerators listed are heavily used in nuclear physics 
research and medical treatment, therefore only limited beam time can be provided to address all 
open issues present for explorative missions. Because in space all particles and energies are 
available, the simulation of the space radiation field at accelerators is a challenging time 
consuming task [Norbury 2015].  
Laser-driven ion beams represent an excellent opportunity to increase the available beam time 
for studies of the biological effects of heavy ions of energies up to 100 MeV/n. Laser facilities 
additionally have the potential advantage of being physically much smaller than particle 
accelerators. The broad distribution of laser-driven ion species and their kinetic energies, if 
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properly controllable, could become a complementary feature to available accelerator sources.  
A detailed description of the needed research topics can be also found in the HUMEX study (see 
website, http://www.dlr.de/me/PortalData/25/Resources/dokumente/publikationen/humex-
summary.pdf) and the THESEUS study (see website, 
http://www.esf.org/fileadmin/Public_documents/Publications /Cluster3_web.pdf). The following 
paragraphs will give a more detailed description of the radiation field in space and its specifics 
followed by a description of biological effects and the studies needed for the radiation risk 
reduction in explorative missions.  
 
14.2 Radiation Fields in Space 
The following description includes only radiation which is relevant to the radiation exposure of 
humans in space. Such types of radiation need energies that are sufficiently high to enter into the 
human body and the ability to ionize the atoms or molecules of the body. The radiation field 
inside the solar system is dominated by our sun and consists of a complex mixture of particles of 
solar and galactic origin. All particles and energies are present in the field [Wilson 1978]. Three 
main sources can be identified: GCR originated outside the solar system, SCR emitted from the 
solar surface and Trapped Radiation (TR) caused by interaction of GCR and SCR with planetary 
magnetic fields.  
There are long term and short term temporal variations caused by the activity of the sun. 
Although different cycles have been already identified [Braun 2005], the most important for the 
radiation field modulation is the Schwabe cycle with a mean duration of approximately 11 years, 
in which the solar activity passes from one solar minimum activity period through a phase of 
maximum activity and back to the next minimum. One continuous measure since 1755 
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describing this activity is the Zürich sunspot number [Hathaway 2002].  
The sun continuously emits particle radiation, primarily electrons and protons: the solar wind. 
Although the particle energies are so low that it would be absorbed within some micrometers of 
tissue, the solar wind is the major driver which determines the extent of the radiation exposure to 
GCR and TR. The solar wind fills out the complete solar system and carries a magnetic field 
which represents a heliocentric potential against which the GCR particles have to work when 
entering the heliosphere. During maximum solar activity the GCR exposure becomes lower, 
since the lower energy particles are no longer capable of entering the solar system. The solar 
modulation of GCR causes a shift of the energy for maximum intensity from solar minimum to 
solar maximum by about 500 MeV, with a strong attenuation of the flux during solar maximum 
below energies of about 30 GeV/nucleon [Badhwar 1997]. GCR are composed mainly of protons 
to about 85% and alpha particles to about 14% with the remainder of about 1% being heavier 
nuclei [Mewaldt 1988].  
In addition, there are also episodes of extreme solar activity in which sudden releases of 
magnetic energy may occur in the corona previously stored in non-potential (stressed) fields, 
which result in Coronal Mass Ejections (CMEs) and Solar Flares. CMEs are huge clouds of 
magnetized plasma expelled from the solar corona into interplanetary space [Chen 2001]. Solar 
Flares manifest themselves as enhanced radiation across the whole electromagnetic spectrum due 
to heating and interaction of high-energetic particles with the solar atmosphere. Both, CMEs and 
solar flares, may be associated with SPEs which cause a radiation hazard to astronauts. Such 
extreme SPEs may last from hours to several days. The high magnetic fields embedded in such 
events lead to a reduction of GCR, the so-called Forbush decreases. On the other hand, a huge 
amount of particles, mostly protons with a small varying amount of heavy ions with energies up 
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to several GeV, can be released. There is no long term forecast for such events. In the case of 
solar flares where the ejected particles immediately spiral around the interplanetary magnetic 
field lines, the travel time to Earth may be in the order of 30 minutes to 1 day, whereas in case of 
CME’s the particles may reach the Earth after 1-4 days. The onset of a SPE can be recorded by 
satellites, but neither the flux nor the energy spectra can be predicted. Energy spectra of 
candidate SPEs demonstrate an enormous variability of energy spectra as well as for the range of 
intensities observed [Wilson 1997]. 
The third radiation source is the radiation belt around the Earth. The radiation belt is a product of 
the interaction of GCR and SCR with the Earth’s magnetic field and the atmosphere [Allkofer 
1975]. The radiation belts extend over a region from 200 km to about 75000 km around the 
geomagnetic equator. The radiation belts consist of electrons and protons, and some heavier ions 
trapped in the magnetic field. Different processes contribute to the build-up of the radiation belts. 
The inner belt is mainly formed by protons and electrons as products from decaying neutrons, 
produced in interaction of cosmic particles with the atoms of the atmosphere. The outer belt is 
filled mainly by solar particles, which are injected during magnetic disturbances caused by 
particle events hitting the Earth. In each zone, the charged particles spiral around the 
geomagnetic field lines and are reflected back between the magnetic poles which act as mirrors. 
At the same time, because of their charge, electrons drift eastwards, while protons and heavy 
ions drift westwards. The electrons reach energies up to 7 MeV, the protons up to 700 MeV with 
a fluence maximum near 100 MeV. As with GCR, the trapped radiation (TR) is modulated by the 
solar activity. With increasing activity the proton flux decreases, while the electron flux 
increases. The proton flux decreases because the Earth’s atmosphere expands leading to a loss of 
protons due to increased interaction with the molecules of the atmosphere. The electron 
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contribution increases because more electrons are fed into the radiation belts through enhanced 
solar activity. The electron fluxes in the outer zone show diurnal variations up to a factor of 16, 
but short term variations may raise the mean flux by two or three orders of magnitude. The flux 
in the center of the inner belt is quite stable. However, at the lower edge of the belt where the 
International Space Station (ISS) is operating electron and proton fluxes may vary by a factor of 
5.   
Charged particles from GCR and SCR have to penetrate the Earth’s magnetic field to reach an 
orbiting spacecraft. For each point inside the magnetosphere there exists a cut-off rigidity which 
is proportional to the magnetic field component perpendicular to the direction of the particle 
motion. To reach this point the particle rigidity (particle momentum divided by its charge) must 
exceed the local geomagnetic rigidity cut-off. The rigidity is a function of the geomagnetic 
latitude and increases from high latitude towards the equator. At the poles the cut-off rigidity is 
zero, so particles of any energy can enter. As a result the GCR flux decreases from the poles to 
the equator. 
14.3 Radiation Fields inside Spacecraft, on Planetary Surfaces and in the Human Body 
The radiation field inside a spacecraft or on planetary surfaces differs significantly from the 
primary field in space. Penetrating spacecraft walls radiation is partly absorbed and secondary 
radiation is produced by scattering and nuclear interaction. Due to the non-homogenous 
distribution of the equipment inside spacecraft, the internal radiation field depends on the 
location inside the spacecraft. On planetary surfaces the field depends on the existence of a 
magnetic field, the thickness and the composition of the atmosphere and the surface material. 
This field is further modified when entering the human body. The analysis of the particle 
transport inside the body is a prerequisite when determining absorbed doses and the risk of early 
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and late effects. 
Several radiation transport codes are in place to allow the calculation of particle fluxes and dose 
rates behind defined shielding. The Boltzmann transport equations for atomic and nuclear 
collisions may be solved by numerical and analytic techniques [Wilson 1993] or by Monte Carlo 
techniques [Ferrari 2001, Agostinelli 2003, Allison 2006, Townsend 2005, Waters 2002, Niita 
2006]. Calculation of doses inside the human body additionally needs to employ computational 
phantoms, which represent the anatomy of the human bodies or parts of it [ICRP 2009, Yucker 
1990, ICRP 2013]. 
The codes have to be validated by measurements with area monitors inside and outside 
spacecraft at well-selected locations with known shielding distributions and by individual 
measurements with personal dosimeters. Organ absorbed dose cannot be measured in the human 
body, therefore human phantoms equipped with radiation monitors are used to provide the 
essential confidence for radiation transport calculations [Reitz 2009].  
Usually, the absorbed dose is the basic quantity to measure radiation exposure. The absorbed 
dose is the quotient of the energy deposited by ionizing radiation within an elemental volume to 
the mass of matter in that volume. The absorbed dose is measured in units of Gray (Gy) (1 Gy = 
1 J/kg (= 100 rad)). Whereas different radiation qualities produce the same type of effect, the 
magnitude of the effect per unit of absorbed dose can be different. For radiation protection, the 
Quality factor (Q) was introduced in order to account for the different relative biological 
efficiencies (RBEs) of different types of ionizing radiation. This factor depends not only on 
appropriate biological data, but primarily it reflects a judgement concerning the importance of 
the biological endpoints. Q is defined in dependence of the linear energy transfer (LET). It is set 
to 1 for LET < 10 keV/µm, in the LET range from 10 - 100 keV/µm to 0.32 * LET - 2.2 keV/µm 
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and for LET > 100 keV/µm to 300 / (LET)0.5 [ICRP 1991]. The dose equivalent at a point is 
defined as the product of absorbed dose and Q. The quantity effective dose equivalent [ICRP 
2013] is the sum of all organ doses which can be calculated as product of Q and absorbed dose 
by additionally applying tissue weighting factors as defined in ICRP103 [ICRP 2007]. The 
effective dose equivalent is given in units of Sievert (Sv) (1 Sv = 1 J/kg (=100 rem)). 
During space missions, astronauts are constantly exposed to GCR. This chronic whole body 
exposure with single energetic particles (electrons, protons, α-particles and heavy ions) results in 
an inhomogeneous dose distribution in the body. The flux is quite low and counts to about 4 
protons, 0.4 Helium ions and 0.04 heavier particles per cm-2 s-1. Therefore, the cells that are hit 
by a single energetic heavy ion are exposed to a high dose, and others that are not hit receive no 
dose at all. The traversing ions produce “ionization channels” in the hit cells and the biological 
effect depends on the extent of damage to sensitive biomolecules. Assuming an ionization 
channel of 10 µm in diameter for iron as example doses can be as high as 100 kGy. The damage 
of DNA DSBs has been visualized by immunofluorescence in a human skin fibroblast exposed to 
2 Gy of ionizing radiation (iron ions); DNA DSBs are located along a particle trajectory 
[Durante 2006]. Therefore the radiation protection system which is based on mean absorbed dose 
is just an approximated surrogate and consequently providing the highest uncertainty in risk 
estimates. 
In interplanetary missions, in addition to this chronic, in average low dose exposure at low dose 
rate, an acute whole body exposure to a high radiation dose at a high dose rate can occur during a 
SPE. For high doses the above mentioned radiation protection quantities should not be used, 
instead the RBE weighted mean absorbed dose in the organ or tissue should be applied which is 
given in Gray equivalents (Gy-Eq). The best estimates of RBE values for the different radiations 
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are given in in ICRP Publication 58 [ICRP 1989]. For protons > 2 MeV a RBE of 1.5 is 
recommended.  
In Low Earth Orbit (LEO), where the ISS is operating, the SPE exposures are low to moderate 
due to a quite efficient geomagnetic shielding, while the contribution of the charged particles 
trapped in the Earth’s magnetic field (Van Allen belts) to the total dose cannot be neglected 
[Facius 2006]. 
 
 
Radiation monitors were flown as part of all human missions and on numerous satellites. In the 
early times of spaceflight passive detectors which integrate dose and flux over time dominated. 
Later on active devices complemented the information on the radiation environment by adding 
temporal information. Good summaries of measurements can be found elsewhere [Badhwar 
2002, Benton 2001, Reitz 2005, Reitz 2008, Casolino 2002, Dudkin 1995, Dudkin 1996]. A 
summary of effective dose equivalent rates for various missions, such as Apollo, Skylab and 
Shuttle missions, MIR and early ISS can be found in a compilation by Cucinotta, 2003. The 
Apollo deep space missions (to the Moon) show mean dose rates up to 3 mSv/day. In these 
missions the nuclei of the GCR dominate the exposure. Shuttle missions with inclination 
between 40 and 60 degrees show very nicely the influence of the solar cycle and maximum 
effective equivalent dose rates up to 1 mSv/day. Up to 4 mSv/day were observed in low 
inclination missions (around 28° inclination) above 600 km altitude whichare a result of the 
higher contribution of the protons from the radiation belt.. The ISS has been operating since 
1998 at an altitude around 400 km and an inclination of about 51.5°; the first long-duration 
human stay was from November 2000 to March 2001. Environmental measurements on board 
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the ISS in June 2016 show equivalent dose rates up to 0.7 mSv/day. For comparison the mean 
exposure rate on Earth is about 0.0066 mSv /day. Measurements on the ISS are permanently 
done by a suite of instruments; results can be found on the web under http://wrmiss.org. Figure 
14.1 shows particle count rates recently measured with a silicon detector of 6.93 cm2 detection 
area on the ISS. The peaks represent proton counts when the ISS is passing through the South 
Atlantic Anomaly, a region where the radiation belt comes closer to the Earth surface. The other 
counts are GCR particles; the maximum flux is in the polar regions, the lowest at the equator.  
A summary of the measurements of the Mars Science Lab Radiation Assessment Detector 
(MSL-RAD) is given in Table 14.1. The table presents the particle flux, dose and dose equivalent 
rates with which we are faced in interplanetary travel or on the surface of Mars. 
 
Figure 14.1: Count rate measurements onboard the ISS of the two DOSTEL telescopes as part of 
the DOSIS experiment (Principal Investigator: Dr. Guenther Reitz (German Aerospace Center). 
The GCR count rates are due to the changing magnetic cut-off conditions during the ISS orbit 
with dependence of latitude; GCR count rates are at a minimum at the magnetic equator and a 
maximum at the highest latitude position; the spikes occur when the ISS is crossing the South 
Atlantic Anomaly of the radiation belt; the peaks are mainly due to protons. (DoY =Day of Year) 
 
 
Table 14.1 Flux, dose and dose equivalent rate measurements of GCR during the cruise to and 
on the surface of Mars by the MSL-RAD 
RAD Measurements Mars Surface Cruise Units 
Differential charged particle 0.26 0.64 Particles cm-2 s-1 sr -1 
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flux density 
Dose Rate 0.21 ± 0.04 0.46 ± 0.06 mGy d-1 
Average Quality Factor <Q> 3.05 ± 0.26 3.82 ± 0.30 (dimensionless) 
Dose Equivalent Rate 0.64 ± 0.06 1.84 ± 0.30 mSv d-1 
 
The dose equivalent rates during cruise, compared to that on ISS, are close to a factor of three 
higher. On the Mars surface we experience about the same exposure as on the ISS. On the Mars 
surface, the exposure is due to GCR only, as in the cruise, where on ISS the radiation field is a 
mixture of protons from the radiation belts and GCR. 
 
The total number of particle hits per cell nucleus (diameter 11.3 µm, area 100 µm2) in the human 
body at average skin depth while exposed during a stay on Mars at the mean surface level during 
one year based on measurements of the Martian Radiation Environment experiment (MARIE) 
arrived at about 40 protons, 1 Helium ion and 0.1 ions with charge greater than two [Saganti 
2002].  
 
Table 14.2 Calculation of dose equivalent for two NASA reference missions based on MSL-
RAD measurements compared to calculation of effective dose equivalent taking into account a 
human body in a space suit on the Mars transfer vehicle and on Mars  
Mission Phase 
Dose Equivalent/ Effective 
Dose Equivalent (Sv) Notes 
Astronaut Career Limits* ~ 0.60  -  1.20 Depends on age, gender, etc. 
Cruise to Mars (180 days) ~ 0.33  /  0.22 Near Solar Max 
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Mars Surface Mission (600 days) ~ 0.38  /  0.24 Thin habitat shielding 
Mars Surface Mission (300 days) ~ 0.19  /  0.12 Thin habitat shielding 
Return to Earth (180 days) ~ 0.33  /   0.22 Near Solar Max 
Total Mission Dose Equivalent  
(300 days on Mars) ~ 0.85  /  0.56  
Total Mission Dose Equivalent 
(600 days on Mars) ~ 1.04  /  0.68  
*Lower and upper values for NASA career limits based on three percent excess risk of fatal cancer 
 
Until now only doses of GCR including ‘belt’ protons in LEO are reported. The doses 
contributed by SPE in interplanetary space vary from zero to a couple of Gy depending on the 
fluence, the shape of the energy spectra and provided shielding thickness. Because the onset of 
the SPE can be monitored (no forecast of fluence or shape of energy spectra is possible), an 
inflight interplanetary crew can at least move to shelter. About 40 g/cm2 of material 
(corresponding for example to 15 cm aluminum) is considered to be sufficient shielding. This 
shelter thickness allows the crew a safe cruise even at times of high solar activity. Excursions on 
planetary surfaces present of course a higher risk, especially on celestial bodies without 
atmospheres. The Mars atmosphere with a shielding thickness of 20 g/cm2 of CO2 provides 
already a complete protection against most SPEs. Housings adequately constructed with 2-3 m 
wall thickness of regolith or located deep enough in caves can guarantee exposure levels close to 
the exposure levels on the Earth surface. 
 
Table 14.2 shows the calculation of dose equivalent and effective dose equivalent based on 
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MSL-RAD measurements compared with calculations of GEANT4 transport model with a 
human phantom implemented in the MSL mission. 
14.4 Effects in Humans  
Astronauts can “see” the exposure to GCR and trapped radiation in form of light flashes when 
they close their eyes [Pinsky 1975]. This phenomenon occurs after about a 15 minute dark 
adaptation and is explained by highly energetic heavy ions that interact directly or indirectly (via 
Cherenkov radiation in vitreous humour) with the retina [Bidoli 2002], or possibly with the optic 
nerve or the visual centers in the brain, producing a visual sensation. 
The extent, type and onset of radiation effects observed in humans depend on the dose, the dose 
rate, the radiation quality and the individual sensitivity of the exposed human or animal (see 
Figure 14.2). Acute radiation effects in humans appear quite soon after exposure to a high dose 
in a short period of time (minutes to a few days). Late effects, such as cancer, can occur after 
years or decades in survivors of radiation exposure and have no threshold dose. Their probability 
for occurrence is proportional to the exposure level. 
 
 
Figure 14.2: Acute, chronic and late effects of radiation exposure. Exposure to ionizing radiation 
produces DNA double strand breaks (pink foci) in the cell nucleus (blue) that can be visualized 
by immunofluorescence staining of the phosphorylated histone H2AX (H2AX). The outcome 
depends on many influencing factors, including the microenvironment of the hit cells and a local 
or systemic immune response. 
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14.4.1 Basic Mechanisms: DNA Damage and Cellular Radiation Response 
Ionizing radiation reacts with cellular macromolecules by direct ionization or indirectly via 
radiolysis of the cellular water. Thereby-generated oxygen radicals attack the DNA molecule and 
disrupt the ribose-phosphate backbone leading to single- and double-strand breaks, and induce 
base damage, loss of bases, or DNA-DNA and DNA-protein crosslinks. Such damage can disturb 
the information carried by the affected DNA molecule. DNA damage is regarded as the central 
element in cell killing by ionizing radiation, whereby DSB are considered to be the most 
cytotoxic damages [Jackson 2009]. These early events after radiation can pave the way to disease 
by activation of the cellular radiation response. 
The cellular response to radiation is predominantly a DNA Damage Response (DDR) (see Figure 
14.3) that detects lesions, signals their presence and promotes their repair [Jackson 2009]. This 
signal transduction pathway involves multiple sensors for different types of DNA lesions, 
transducer molecules and a variety of effector molecules and enzymes for repair. As radiation 
can simultaneously activate multiple pathways [Dent 2003], the DDR results in potentially cell-
protective (cell cycle arrest, DNA repair, survival) or cell-altering (misdifferentiation, premature 
differentiation, senescence, mutations) or even destructive responses (different types of cell 
death) [Khanna 2001, NASA 2004, Ohnishi 2002]. 
 
Figure 14.3: The DNA damage response as central element of the biological reaction to ionizing 
radiation exposure and the different outcomes 
 
14.4.2 Non-targeted Effects 
In addition to the direct effects on DNA as the main biological target, non-targeted effects such 
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as the bystander effect and the adaptive response can influence the outcome after exposure to 
ionization radiation and are therefore important for space radiation risk assessment. Bystander 
cells are not directly exposed or traversed by radiation, but are in the neighborhood of a cell that 
had been hit or are incubated with medium from irradiated cells, and show responses [Mothersill 
2004]. 
14.4.3 Acute Effects 
SPE events pose the risk of acute high doses and high dose rate exposures. A large SPE such as 
the one that occurred in August 1972 might result in absorbed dose rates as high as 1.4 Gy/h 
Parsons 2000]. Exposure to an acute single dose elicits the acute radiation syndrome (Fehler! 
Verweisquelle konnte nicht gefunden werden.14.3), also known as radiation sickness, with 
symptoms depending on absorbed total radiation dose, type of radiation, the dose distribution in 
the body and the individual radiation sensitivity [Cronkite 1964, Drouet 2010]. A rapid onset of 
nausea, vomiting, and malaise (absorbed dose > 0.5 Gy) characterizes the prodromal stage, 
which is followed by a nearly symptom-free latent phase of weeks to days, depending on dose. 
The prodromal stage can be life threatening, if vomiting occurs while the astronaut performs an 
EVA in a space suit. 
The acute radiation syndrome affects the tissues with rapid turnover in the first place. Cellular 
fate is determined by decision between cell death and survival. Accordingly, the effects on the 
individual result from depletion of already differentiated cells by cell death mechanisms, and 
from failing replacement by stem cells due to cell cycle block and cell death. Only cells 
overcoming the cell cycle block are able to replace radiation-damaged tissue to regain its normal 
function. 
The bone marrow is one of the most radiosensitive organs in the body. In the manifest phase of 
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radiation sickness, depression of its function (bone marrow or hematopoietic syndrome) appears 
in humans exposed to doses of 0.7 - 4 Gy. These doses are lower compared to those eliciting the 
gastrointestinal tract syndrome (5- 12 Gy) or the CNS syndrome (> 20 Gy). The lethal dose for 
50% of the exposed human individuals within 30 days was estimated to be 3-4 Gy (LD50/30).   
Recent studies suggest that in all three sub-syndromes, exacerbated innate immune responses 
play a major role in pathogenesis [Drouet 2010, Jacob 2010, Van der Meeren 2005]. Epithelial 
and endothelial cells are suggested as sources of the pro-inflammatory cytokines in the acute 
radiation syndrome [Van der Meeren 2005]. Immune suppression is the predominant feature of 
the bone marrow syndrome. Due to the longer lifespan of erythrocytes, anemia develops later 
(within 2-6 weeks) than the lymphopenia. Death usually occurs from sepsis at 30-60 days after 
radiation exposure, if the patient cannot be carried through the critical period of the possibly 
reversible aplastic state of the bone marrow [Cronkite 1964]. Cytological abnormalities 
(multipolar mitosis, micronuclei, mitotic bridges, binucleated cells) and a reduced mitotic index 
were observed in human bone marrow cells (e.g. erythroblasts) during the first days after 
accidental sublethal whole body -radiation exposure, and cytological abnormalities persist at a 
lower frequency for years after the accident [Fliedner1964]. 
The gastrointestinal tract syndrome appears after a short latent period after whole-body 
irradiation with 5 - 12 Gy. It is due to loss of the intestinal epithelium after massive cell death 
and lack of mitotic success in the intestinal epithelium crypts, and injury to the fine vasculature 
of the submucosa. Invading bacteria produce local and systemic inflammation and sepsis with 
multiple organ failure [Drouet 2010]. Enhanced by the concomitant immunosuppression, death 
occurs between three and ten days post-exposure. If some crypt cells survive, they will 
regenerate functional crypts and repopulate the villi. 
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The onset of the CNS syndrome occurs after a very short latent period of several hours to days 
after exposure to very high acute doses (> 20 Gy in humans). Cells with highest differentiation 
status and lowest reproductive capacity, the neurons, are affected. The prognosis is fatal.  
In spaceflight, exposure to mostly protons during a large SPE could result in the acute radiation 
syndrome. Experiments with mice have shown, that 2 Gy of protons delivered within 36 hours 
induce anemia and immunosuppression with decreased numbers of erythrocytes, lymphocytes, 
monocytes and granulocytes, and a decreased relative spleen mass [Gridley 2008]. In mice 
exposed to 3 Gy of protons, a strong immune depression was observed already 12 hours after 
exposure, with the nadir on day 4 [Kajioka 2000]. Increased susceptibility to infections, cancer 
induction by promotion of initiated cells, and disorders of the immune system such as 
autoimmunity or hypersensitivity are possible consequences of the immunosuppression. 
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Table 14.3 The Acute Radiation Syndrome 
Dose 
range 
(Gy) 
Sub-
syndr
ome 
or 
stage 
Affected 
cells / tissues 
Symptoms Therapeutic 
approach 
Refer-
ences 
> 0.5  Prodr
omal 
stage 
Neurons in 
the CNS, e.g. 
in the caudal 
medulla, 
Nervus vagus 
Rapid onset of nausea, 
vomiting, and malaise 
Antiemetics [Makale 
1993, 
Tofilon 
2000, 
Marquette 
2003] 
0.5-4  Hema
topoie
tic  
Bone marrow 
stem cells 
including 
megakary-
oblasts 
Progressive 
lymphopenia, immune 
system suppression, 
susceptibility to 
infections, 
thrombocytopenia with 
increased bleeding 
tendency, early 
granulocytosis followed 
by progressive 
granulocytopenia, 
anemia 
Antibiotics, 
antifungal drugs, 
isolation, 
electrolyte & 
platelet or blood 
transfusions, 
Granulocyte 
Colony-
Stimulating 
Factor (G-CSF), 
allogenic bone 
marrow 
transplantation 
[Cronkite 
1964, 
Dainiak 
2003, 
Chao 
2007, 
Drouet 
2010]  
5-12  Gastr
ointes
tinal  
Differentia-
ting cell 
compartment 
– stem cells 
in crypts; 
endothelial 
cells, 
activation of 
the innate 
immune 
system 
Diarrhoea, sepsis, 
multiple organ failure; > 
10-12 Gy: 100% lethality 
[Drouet 
2010, 
Jacob 
2010, 
Gaugler 
2005, 
Singer 
2004,Gou
rlemon 
2005] 
> 20-
30 
Neuro
vascul
ar 
Mature 
functioning 
cells: neurons 
and 
endothelial 
tissue 
Loss of coordination, 
confusion, convulsions, 
eventually coma, and 
signs of the bone marrow 
and gastrointestinal 
syndromes, vomiting, 
dehydration, cerebral 
none [Jacob 
2010] 
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edema, injuries to the 
nerves, death occurs 
within few days or hours 
 
 
Therapeutic approaches for the acute radiation syndrome were tested in non-human primates; 
dogs, mice, rats and pigs [McVittie 2005, Donnadieu-Claraz 1999] and in accidently irradiated 
humans. The efficacy of other growth factors, such as Keratinocyte Growth Factor (KGF) and 
combinations of different growth factors (Stem Cell Factor - SCF, Nerve Growth Factor - NGF, 
erythropoietin, pegylated growth factors), antioxidants (e.g. N-acetyl cysteine) and anti-
inflammatory approaches (e.g. inhibitors of cyclooxygenase-2- COX-2-, anti-IL-antibodies, 
curcumin, Ghrelin) are currently under investigation [Drouet 2010, Jacob 2010, Neal 2003]. 
In case of high dose SPEs astronauts have to be protected by a warning system allowing 
movement to a radiation shelter. 
 
14.4.4 Chronic and Late Effects 
Delayed or chronic effects of radiation exposure include cancer and non-cancer effects such as 
degenerative diseases. Cancer induction is a highly relevant and life threatening late effect of 
radiation exposure by radiation accidents, in atomic bomb survivors, for human spaceflight or 
radiotherapy. Ionizing radiation can definitively provoke tumor initiation, due to its DNA 
damaging effects. The role of radiation in tumor promotion and progression is less clear.  
In radiotherapy, induction of secondary tumors by low radiation doses to the tumor-surrounding 
tissue occurs stochastically. The probability of tumor induction in the dose range below 1 Gy 
was derived from the cancer incidence (solid tumors, leukemia) in atomic bomb survivors who 
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were exposed at high dose rates [Pierce 1996, Pierce 2000]. With increasing survival times of 
patients after cancer radiotherapy, there is growing concern for the risk of secondary cancer, 
especially in children who are inherently more radiosensitive [Baskar 2010]. These 
epidemiological data were derived almost entirely from low-LET radiation exposures. 
Human data for cancer risk by GCR, especially high-LET heavy ions, are absent, and 
radiobiological data are limited. Currently, the quality factor (Q) for biological weighting of the 
GCR dose is governed by results derived from experiments with mice revealing a very high RBE 
for induction of tumors of the Harderian gland by heavy ions (LET > 100 keV/µm) [Fry 1983, 
Alpen 1994]. During a long-term space exploration mission, astronauts accumulate high 
exposures to GCR. A causal relationship between the frequency of chromosomal aberrations in 
peripheral blood lymphocytes and cancer allows estimation of cancer risk by appropriate analysis 
of the aberration frequency [Durante 2001]. A significant increase in chromosomal aberrations 
was observed in astronauts after long duration flights [George 2001]; data on cancer in astronauts 
are limited and lack statistical confidence, due to small group size [Longnecker 2004]. By the 
chromosomal aberration risk assessment technique, the cancer risk after a long-term mission on 
the former Russian space station Mir was estimated to be increased by 20 – 30% compared to a 
control group [Durante 2001]. For a Mars mission the uncertainties in cancer risk projections 
were estimated to be 400-600% [Cucinotta 2001a]. The latter projection involved many 
biological and physical factors, each adding a different range of uncertainty attributed to limited 
data and knowledge to the overall uncertainty. Several factors contribute to the overall 
uncertainty from which radiation quality is the major contributor followed by dose rate effects, 
others are risk transfer across populations, dosimetry, errors in human data and microgravity 
[Durante 2008]. 
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Different organs can be affected by radiation-induced degenerative disease, e.g. the eye lens, and 
the central nervous, digestive, respiratory, endocrine, immune system or cardiovascular system. 
The eye lens is a quite radiosensitive tissue, as it has no mechanism for removal of dead or 
damaged cells and is not connected to the blood stream. During life, lens epithelial cells are 
continuously produced by mitosis in the germination zone of the lens and they differentiate into 
transparent lens fibers. Cataracts are detectable changes in the normally transparent lens of the 
eye; for example, resulting from disturbed differentiation into lens fibers. The threshold for 
cataract formation after protracted radiation exposure was as low as 2 Gy for sparsely ionizing 
radiation. Other investigators suggest even a threshold of 100-300 mGy for cataract formation, or 
dismiss any threshold [Worgul 1999]. Concluding from studies with rabbits exposed to neon or 
argon ions, Lett supposed that astronauts could experience late radiation effects one or more 
decades after a long-term space mission beyond LEO [Lett 1980]. In mice and rats exposed to 
energetic heavy ions, it was shown that high LET ionizing radiation is especially effective in 
cataract formation, even at doses below 2 Gy [Worgul 1989, & 1993, Hall 2006]. A lower 
threshold for cataracts of about 100 mGy was published recently by Blakely et al. [Blakely 
2010]. Late cataractogenesis in Rhesus monkeys (Macaca mulatta with median life span near 24 
years) was observed about 20 years after the exposure to protons of different energies, and in 
rabbits after exposure to energetic iron ions [Cox 1992, Lett 1991]. Besides animal experiments, 
data from radiotherapy patients are used for space radiation risk assessment concerning cataract 
formation or cancer induction in astronauts [Lett 1994, Wu 1994, Blakely 1994]. Up to now, lens 
opacities are the only proven space radiation late effect in astronauts [Cucinotta 2001b, Rastegar 
2002] and they occur with higher frequency in astronauts exposed to higher proportions of high 
LET-radiation [Cucinotta 2001b]. As cataract surgery can restore the vision, it is not warranted 
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to consider cataractogenesis as a major critical health risk in short to medium-term spaceflight, in 
view of an overall mission death risk of a few percent. During long-term missions that can occur 
over several years, the expression time for cataracts has to be considered. During such missions, 
a cataract might develop before return to Earth and thereby it represents a mission risk. 
During an interplanetary mission, astronauts can accumulate a considerable number of hits at 
critical sites of the brain [Craven 1994, Curtis 1998]. This gives rise to concern about CNS 
effects that could reduce the neurocognitive performance of the crew during the mission. 
Possible mechanisms are induction of DNA damage and cell death in neurons and neural 
precursor cells, disturbance of neurogenesis, electrophysiological activity, synaptic plasticity and 
neurotransmitters, neuroinflammation and oxidative stress [Rola 2005, Limoli 2007, Rola 2008, 
Vlkolinsky 2007,Machida 2010, Tseng 2014, Rivera 2013, DeCarolis 2014, Baulch 2015]. 
Animal experiments revealed learning, memory and executive function deficits after heavy ion 
exposure [Rabin 2000, Rabin 2005, Britten2012, Lonart 2012]. 
In cancer therapy patients, an elevated risk for cardiovascular disease has been known for 
decades. Recent epidemiological data show that also low dose exposure can result in 
cardiovascular effects [Bhattacharya 2015] and has to be considered in space radiation risk 
assessment [Boerma 2015]. Ionization radiation can affect e.g. endothelial cells or 
cardiomyocytes [Soucy 2011, Colemann 2015]. 
14.5 Ground-based Research  
The limited knowledge of the biological effects from exposure to heavy charged particles is an 
ongoing concern in human spaceflight [Cucinotta 2011]. Open questions in space radiation 
biology are the difference in mechanisms for high vs. low LET radiation, the extent of the dose 
rate effect and the radiation quality dependence, the extrapolation of cell culture and animal data 
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to humans, and the individual radiation sensitivity (radio sensitivity syndromes represent the 
extremes; polymorphisms) all contributing to the radiation risk assessment. The atomic bomb 
survivor data serve as main reference for radiation risk estimates of space radiation, but the 
exposure conditions for the survivors and astronauts are quite different (Table 14.4). The 
exposure profile in space differs quite substantially from those which usually apply for reference 
experiments or data sources on Earth; especially where fluence rates and time scales are 
concerned.  
Limited data are available for non-cancer late effects, e.g. cataracts and cardiovascular diseases. 
A quantitative risk assessment of CNS effects is completely missing [Cucinotta 2013].  
 
Table 14.4 Differences in exposure conditions of the atomic bomb survivors (reference for 
radiation risks) and astronauts in space 
 
Exposure 
Parameters 
Atomic Bomb Exposure § Space Exposure 
Dose rate, duration Instantaneous/acute, seconds  GCR: chronic/protracted, months – 
years;  
SPE: acute, hours-days 
Radiation quality Low LET gamma rays Most complex mixture of disparate 
radiation qualities conceivable 
Body distribution Essentially homogeneous  Depending on external shielding, 
inner organs largely homogeneous 
Exposed population Common age, gender, health Selected for physical/ psychic 
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status distribution of a city 
population  
prowess, age, and health  
Environmental 
conditions  
Normal terrestrial Microgravity, confined ecological 
system, artificial/technical 
components dominating 
§: Data Base: atomic bomb survivor epidemiology    
 
Understanding acute effects requires data for whole body and partial body irradiation. Accidental 
exposures to SPEs result in inhomogeneous irradiation of the body, depending on the slope of 
energy spectra and exposure situations. There are no data on dose rate dependency for acute 
effects. Modification of the radiation response through the spaceflight environment is totally 
neglected in all agency radiation protection programs. 
 
Experimental data on molecular and cellular mechanisms in cell, tissue and organ cultures are 
needed, and animal studies are required for studies on cancerogenesis, degenerative diseases and 
countermeasure testing. It needs to be proven whether or not the prodromal syndromes are 
different in humans and animal systems. As astronauts in a space suit or in a planetary habitat 
live in an atmosphere different of that on Earth, effects of altered oxygen and carbon dioxide 
concentrations, leading to hypoxia or hyperoxia or hyperkapnia certainly cannot be neglected.  
Furthermore countermeasures have to be provided, such as shielding and biomedical approaches 
(diet and radioprotectors). Effective biomedical countermeasures beyond amifostine and 
antioxidants have to be developed by ground-based research with appropriate models. Most 
recently it was found that CDDO-Me (bardoxolone methyl) showed a dose reduction factor 
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(DRF) of almost 2, which is very promising. Clinical tests indicate that it shows minimal toxicity 
in animal studies [Eskiocak 2010]. Ion sources are also needed for detector development and 
characterization to allow for ground and space borne intercomparisons. Improved detectors are 
needed to provide field dosimetry. 
 
14.6 Summary 
This chapter is intended to provide the major dosimetric features that are needed to draw a 
picture of which particle types, fluences and doses are required to perform reliable space 
radiation simulation. Because this picture is far from being complete, please refer for more 
detailed information to cited literature. The chapter also lists major biological questions that must 
be solved in order to reduce the uncertainties of risk estimates. The simulation of the radiation 
field in space is rather difficult due to the mixture of particles needed and by the rather long 
exposure times required to accumulate significant dose in the human body or the cell system 
under investigation. A recent paper describes in detail the needs for a GCR simulation [Norbury 
2016]. The state of laser-driven heavy ion beams is currently far from providing all particle 
energies that are present in space. However, it is valuable to employ such laboratory sources 
providing a range of particles and kinetic energies for space research. The laser-driven case for 
energetic electron and ion production is in an early stage of development and we can expect 
useful advancements of this technology. We envisage protons and heavy ions with kinetic 
energies up to 100 MeV/n for this new laser-driven technique. (see chapters 2, 4 and 5 (Part I) 
for electron and ion acceleration status with high power lasers). For example many biological 
investigations require high LET, which means that energies of 20-50 MeV/n (with carbon for 
example) can be efficient for acquiring missing radiobiological data. Although laser-driven 
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particle fluences can be very high and therefore suited to provide high doses in short time, space 
reference systems typically require low particle fluences continuously distributed over an 
extended period. Therefore it can be a challenging task to reduce flux levels using collimator 
optics. A notable advantage of  laser-driven ion sources is there emission characteristics, i.e. the 
broad angular divergence which reduces fluence quickly over a certain distance from the source 
and enables large field irradiation in a potentially compact setup. A second key advantage might 
be the intrinsically broad energy distributions of laser-driven ion sources – so, one can consider 
irradiating samples with a broad energy spectrum which comes closer to the space environment 
than an ion beam of well-defined energy at a conventional accelerator. A third key advantage 
might be the intrinsic capability of the laser-driver to generate multiple synchronous beams with 
different particles, again better simulating the real space environment if properly controllable. 
Those potential advantages usher optimism that laser-driven particle sources can expand the 
experimental toolbox for radiation biological studies. In particular, they can help to close the 
current gap for facility beam time for radiation biologists to answer the open questions and to 
reduce the extraordinarily large uncertainties in radiation biology for explorative missions. 
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